These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11402470)

  • 1. Dexmedetomidine, a novel alpha 2-adrenergic agonist for short-term sedation in the intensive care unit.
    Le T
    Conn Med; 2001 May; 65(5):269-72. PubMed ID: 11402470
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of dexmedetomidine in Chinese post-surgical intensive care unit patients.
    Lin L; Guo X; Zhang MZ; Qu CJ; Sun Y; Bai J
    Acta Anaesthesiol Scand; 2011 Mar; 55(3):359-67. PubMed ID: 21288220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit.
    Martin E; Ramsay G; Mantz J; Sum-Ping ST
    J Intensive Care Med; 2003; 18(1):29-41. PubMed ID: 15189665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine (Precedex) for ICU sedation.
    Med Lett Drugs Ther; 2011 May; 53(1365):41-2. PubMed ID: 21617592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating agitation with dexmedetomidine in the ICU.
    Boyer J
    Dimens Crit Care Nurs; 2009; 28(3):102-9. PubMed ID: 19387269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative intensive care unit drug fever caused by dexmedetomidine.
    Okabe T; Takeda S; Akada S; Hongo T; Sakamoto A
    Anesth Analg; 2009 May; 108(5):1589-91. PubMed ID: 19372340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters.
    MacLaren R; Forrest LK; Kiser TH
    Pharmacotherapy; 2007 Mar; 27(3):351-9. PubMed ID: 17316147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists.
    Panzer O; Moitra V; Sladen RN
    Crit Care Clin; 2009 Jul; 25(3):451-69, vii. PubMed ID: 19576524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dexmedetomidine, a promising drug].
    Mato M; Pérez A; Otero J; Torres LM
    Rev Esp Anestesiol Reanim; 2002 Oct; 49(8):407-20. PubMed ID: 12455321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients.
    Baddigam K; Russo P; Russo J; Tobias JD
    J Intensive Care Med; 2005; 20(2):118-23. PubMed ID: 15855224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit.
    Arpino PA; Kalafatas K; Thompson BT
    J Clin Pharm Ther; 2008 Feb; 33(1):25-30. PubMed ID: 18211613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children.
    Berkenbosch JW; Wankum PC; Tobias JD
    Pediatr Crit Care Med; 2005 Jul; 6(4):435-9; quiz 440. PubMed ID: 15982430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: dexmedetomidine: does it have potential in palliative medicine?
    Prommer E
    Am J Hosp Palliat Care; 2011 Jun; 28(4):276-83. PubMed ID: 21131636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine: new insights.
    Mantz J; Josserand J; Hamada S
    Eur J Anaesthesiol; 2011 Jan; 28(1):3-6. PubMed ID: 20881501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine: pediatric pharmacology, clinical uses and safety.
    Su F; Hammer GB
    Expert Opin Drug Saf; 2011 Jan; 10(1):55-66. PubMed ID: 20718689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dexmedetomidine and clonidine: a review of their pharmacodynamy to define their role for sedation in intensive care patients].
    Pichot C; Longrois D; Ghignone M; Quintin L
    Ann Fr Anesth Reanim; 2012 Nov; 31(11):876-96. PubMed ID: 23089375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine: a review of clinical applications.
    Carollo DS; Nossaman BD; Ramadhyani U
    Curr Opin Anaesthesiol; 2008 Aug; 21(4):457-61. PubMed ID: 18660652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine: an updated review.
    Gerlach AT; Dasta JF
    Ann Pharmacother; 2007 Feb; 41(2):245-52. PubMed ID: 17299013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.
    Bejian S; Valasek C; Nigro JJ; Cleveland DC; Willis BC
    Cardiol Young; 2009 Feb; 19(1):98-104. PubMed ID: 19154626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of a G protein-coupled inwardly rectifying K+ current and suppression of Ih contribute to dexmedetomidine-induced inhibition of rat hypothalamic paraventricular nucleus neurons.
    Shirasaka T; Kannan H; Takasaki M
    Anesthesiology; 2007 Oct; 107(4):605-15. PubMed ID: 17893457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.